These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 9678718
1. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARalpha-mediated signals in myeloid leukemic cells. Ueno H, Kizaki M, Matsushita H, Muto A, Yamato K, Nishihara T, Hida T, Yoshimura H, Koeffler HP, Ikeda Y. Leuk Res; 1998 Jun; 22(6):517-25. PubMed ID: 9678718 [Abstract] [Full Text] [Related]
2. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP. Blood; 1996 Mar 01; 87(5):1977-84. PubMed ID: 8634447 [Abstract] [Full Text] [Related]
3. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Shiohara M, Dawson MI, Hobbs PD, Sawai N, Higuchi T, Koike K, Komiyama A, Koeffler HP. Blood; 1999 Mar 15; 93(6):2057-66. PubMed ID: 10068679 [Abstract] [Full Text] [Related]
4. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways. Defacque H, Sévilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T. Leukemia; 1997 Feb 15; 11(2):221-7. PubMed ID: 9009084 [Abstract] [Full Text] [Related]
5. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Mehta K, McQueen T, Neamati N, Collins S, Andreeff M. Cell Growth Differ; 1996 Feb 15; 7(2):179-86. PubMed ID: 8822201 [Abstract] [Full Text] [Related]
6. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Brooks SC, Kazmer S, Levin AA, Yen A. Blood; 1996 Jan 01; 87(1):227-37. PubMed ID: 8547646 [Abstract] [Full Text] [Related]
7. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60. Grillier I, Umiel T, Elstner E, Collins SJ, Koeffler HP. Leukemia; 1997 Mar 01; 11(3):393-400. PubMed ID: 9067579 [Abstract] [Full Text] [Related]
8. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen. Mehta K, McQueen T, Manshouri T, Andreeff M, Collins S, Albitar M. Blood; 1997 May 15; 89(10):3607-14. PubMed ID: 9160665 [Abstract] [Full Text] [Related]
9. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Wu Q, Dawson MI, Zheng Y, Hobbs PD, Agadir A, Jong L, Li Y, Liu R, Lin B, Zhang XK. Mol Cell Biol; 1997 Nov 15; 17(11):6598-608. PubMed ID: 9343423 [Abstract] [Full Text] [Related]
10. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells. Kizaki M, Ikeda Y, Tanosaki R, Nakajima H, Morikawa M, Sakashita A, Koeffler HP. Blood; 1993 Dec 15; 82(12):3592-9. PubMed ID: 8260698 [Abstract] [Full Text] [Related]
11. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR. Monczak Y, Trudel M, Lamph WW, Miller WH. Blood; 1997 Nov 01; 90(9):3345-55. PubMed ID: 9345016 [Abstract] [Full Text] [Related]
12. Existence of retinoic acid-receptor-independent retinoid X-receptor-dependent pathway in myeloid cell function. Hida T, Tai K, Tokuhara N, Ishibashi A, Kikuchi K, Hibi S, Yoshimura H, Nagai M, Yamauchi T, Kobayashi S. Jpn J Pharmacol; 2001 Jan 01; 85(1):60-9. PubMed ID: 11243576 [Abstract] [Full Text] [Related]
13. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Schneider SM, Offterdinger M, Huber H, Grunt TW. Cancer Res; 2000 Oct 01; 60(19):5479-87. PubMed ID: 11034091 [Abstract] [Full Text] [Related]
14. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells. Makishima M, Shudo K, Honma Y. Biochem Pharmacol; 1999 Mar 01; 57(5):521-9. PubMed ID: 9952315 [Abstract] [Full Text] [Related]
15. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP. Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928 [Abstract] [Full Text] [Related]
16. Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Nagy L, Thomázy VA, Chandraratna RA, Heyman RA, Davies PJ. Leuk Res; 1996 Jun 01; 20(6):499-505. PubMed ID: 8709622 [Abstract] [Full Text] [Related]
17. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha. Szondy Z, Reichert U, Bernardon JM, Michel S, Tóth R, Karászi E, Fésüs L. Biochem J; 1998 May 01; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303 [Abstract] [Full Text] [Related]
18. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirier GG, Fontana JA. Blood; 1997 Jun 15; 89(12):4470-9. PubMed ID: 9192771 [Abstract] [Full Text] [Related]
19. Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. Agarwal N, Mehta K. Biochem Biophys Res Commun; 1997 Jan 13; 230(2):251-3. PubMed ID: 9016759 [Abstract] [Full Text] [Related]
20. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Ikezoe T, Tanosaki S, Krug U, Liu B, Cohen P, Taguchi H, Koeffler HP. Blood; 2004 Jul 01; 104(1):237-42. PubMed ID: 15026318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]